查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790313

深奥测试市场规模、份额和趋势分析报告：按类型、技术、最终用途、地区和细分市场预测，2025 年至 2030 年

Esoteric Testing Market Size, Share & Trends Analysis Report By Type (Oncology Testing, Infectious Disease Testing, Infectious Genetic Testing), By Technology, By End Use (Hospital-based Laboratories) By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

深奥测试市场摘要

2024 年全球深度检测市场规模估计为 246 亿美元，预计到 2030 年将达到 479.8 亿美元，2025 年至 2030 年的复合年增长率为 11.8%。这一市场成长是由对早期疾病诊断的需求不断增长和癌症患病率上升所推动的，这推动了对更安全的诊断选择的需求。

根据美国生物技术资讯中心 (NCBI) 的数据，预计到 2025 年，美国将确诊约 2,041,910 例癌症病例，造成 618,120 人死亡。目前可用的深度检测方案具有良好的成长潜力，且市场对技术先进且价格合理的检测需求旺盛，预计将在未来几年推动市场成长。此外，独立实验室和参考实验室对先进深度检测技术的采用预计将推动深度检测产业的发展。

特殊检测对于识别特定基因和生物标记以製定个人化治疗计划至关重要。例如，2023 年 2 月，罗氏宣布延长与杨森的合作关係，并进一步加强研究和创新活动，透过专注于伴随诊断来推进个人化医疗。全球个人化医疗偏好日益增长，预计将在未来几年推动产品需求。即时聚合酵素链锁反应(PCR) 和次世代定序等技术进步正在推动外科医生和患者对特殊检测的偏好，预计这将成为高阶诊断需求的主要驱动力。特殊诊断的例子包括罕见疾病的基因检测、罕见感染疾病的专门检测和高级生物标记检测。与标准的血液和尿液检查相比，特殊诊断通常委託拥有必要设备和人员的参考实验室。由于这些测试具有很高的特异性和有效性，它们在某些治疗环境和科学研究中很有价值。

个人化医疗的日益增长趋势显着增加了对特殊检测的需求。这些专门的检测会检查患者的基因组成、蛋白质谱和生物标记，以确定针对每位患者的标靶治疗。随着人们对个人化医疗和精准诊断的认识不断提高，对有针对性和客製化的检测策略的需求也日益增长。政府倡议多地提供各种便利设施，包括诊断检测报销，预计也是推动市场发展的主要因素。许多医疗机构正在与实验室合作，整合各种特殊检测。

过去几年，政府和私人保险公司提供的政策扩大了这些检查的覆盖范围。因此，支持性的报销和监管政策也是市场的主要驱动力。医疗保险（Medicare）和医疗补助（Medicaid）提高了各种特殊检查的报销额度。此外，私人保险公司正在与非製药实验室合作，为患者提供价格合理的检查，从而降低患者的自付费用，并增加特殊检查的可及性，进一步推动市场成长。

目录

第一章调查方法与范围

第二章执行摘要

3. 深奥测试市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 深奥的测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 深奥测验市场：类型评估与趋势分析

  • 类型细分仪表板
  • 深奥测试市场：类型变化分析
  • 全球深奥测试市场规模与趋势分析（按类型）（2018-2030）
  • 肿瘤学检测
  • 传染病检查
  • 基因检测
  • 内分泌检查
  • 毒性测试
  • 神经学检查
  • 其他的

第五章：深奥测验市场：技术评估与趋势分析

  • 技术细分仪表板
  • 深奥测试市场：技术变革分析
  • 全球深层测试市场规模与趋势分析（按技术，2018-2030 年）
  • 化学冷光免疫检测
  • 酵素免疫分析法
  • 质谱法
  • 即时聚合酵素链锁反应
  • 流式细胞技术
  • 其他的

6. 深奥测试市场：最终用途估计与趋势分析

  • 类型细分仪表板
  • 深奥测试市场：最终用途变异分析
  • 全球综合测试市场规模及趋势分析（依最终用途，2018-2030）
  • 医院附设检查室
  • 独立和参考实验室
  • 其他的

7. 深奥测试市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲（MEA）
    • 阿根廷
    • 南非
    • 南阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • Key Company Heat Map Analysis, 2024
  • 公司简介
    • Labcorp.
    • OPKO HEALTH, INC.
    • Quest Diagnostics Incorporated
    • Sonic Healthcare Limited
    • HU Group Holdings, Inc.
    • Kindstar Globalgene Technology, Inc.
    • Stanford Health Care
    • Mayo Foundation for Medical Education and Research
    • ARUP Laboratories
    • Athena Esoterix
    • ACM Global Laboratories
    • Healius Limited.
Product Code: GVR-4-68040-272-6

Esoteric Testing Market Summary

The global esoteric testing market size was estimated at USD 24.6 billion in 2024 and is projected to reach USD 47.98 billion by 2030, growing at a CAGR of 11.8% from 2025 to 2030. The market growth can be attributed to the increasing demand for early disease diagnosis and the rising prevalence of cancer, which impels the demand for safer diagnostic options.

According to the National Center for Biotechnology Information (NCBI), around 2,041,910 cancer cases will be diagnosed, with 618,120 cancer deaths expected in the U.S. in 2025. The lucrative growth potential of currently available esoteric testing options and high demand for technologically advanced and affordable tests are the factors expected to drive the market growth in the coming years. Moreover, the adoption of advanced esoteric testing technologies in independent and reference laboratories is anticipated to drive the esoteric testing industry.

Esoteric tests are crucial in identifying particular genetic markers and biomarkers to develop personalized treatment plans. For instance, in February 2023, F. Hoffmann-La Roche Ltd announced the extension of its collaboration with Janssen to advance personalized healthcare by focusing on companion diagnostics, further strengthening research and innovation activities. Thus, the rising preference for personalized medicine worldwide is anticipated to boost product demand in the coming years. The growing inclination of surgeons and patients for esoteric tests due to technological advancements, such as real-time Polymerase Chain Reaction (PCR), next-generation sequencing, and others, is anticipated to be a key driver of the rising demand for advanced diagnostics. Examples of esoteric diagnostics are genetic tests for uncommon illnesses, specialized tests for unusual infections, and advanced biomarker assays. In contrast to standard blood or urine testing, esoteric diagnostics are usually outsourced to reference labs equipped with the necessary equipment and personnel. These tests can be beneficial in specific therapeutic settings or scientific investigations owing to their high specificity and effectiveness, even though the demand is usually low due to the high cost.

The growing trend toward personalized treatment has led to a significant increase in the need for esoteric tests. To identify targeted therapies specific to each patient, these specialized tests examine a patient's genetic composition, protein profiles, and biomarkers. With the growing adoption of personalized medicine and precision diagnostics due to increased awareness, targeted and customized testing strategies are becoming increasingly necessary. An increase in initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests, is another major factor anticipated to drive the market. Many healthcare institutions are working with laboratories to integrate different esoteric tests.

Over the last few years, the coverage for these procedures by policies offered by government and private insurance providers has increased. Hence, supportive reimbursement and regulatory policies also act as key drivers of the market. Medicare and Medicaid have increased reimbursement for various esoteric tests. In addition, private insurers are collaborating with esoteric labs to offer patients affordable tests, which lower out-of-pocket costs for patients and increase access to esoteric tests, thereby driving market growth.

Esoteric Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels as well as provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the esoteric testing market report on the basis of product, technology, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology testing
  • Infectious disease testing
  • Genetic testing
  • Endocrinology testing
  • Toxicology testing
  • Neurology testing
  • Others
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemiluminescence immunoassay
  • Enzyme-linked immunosorbent assay
  • Mass spectrometry
  • Real time polymerase chain reaction
  • Flow cytometry
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital-based laboratories
  • Independent and reference laboratories
  • Other
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Technology Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Esoteric Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Esoteric Testing Market: Type Movement Analysis
  • 4.3. Global Esoteric Testing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. Oncology Testing
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Infectious Disease Testing
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Genetic Testing
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. Endocrinology Testing
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.8. Toxicology Testing
    • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.9. Neurology Testing
    • 4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Esoteric Testing Market: Technology Movement Analysis
  • 5.3. Global Esoteric Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Chemiluminescence Immunoassay
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Enzyme-linked Immunosorbent Assay
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Mass Spectrometry
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Real Time Polymerase Chain Reaction
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Flow Cytometry
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. Esoteric Testing Market: End Use Movement Analysis
  • 6.3. Global Esoteric Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital-based Laboratories
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Independent and Reference Laboratories
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Continuous Bioprocessing Market By Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa (MEA)
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Middle East & Africa (MEA)Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. South Africa
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. South Arabia
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.5. UAE
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.6. Kuwait
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Framework/Reimbursement Structure
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Labcorp.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Type Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. OPKO HEALTH, INC.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Type Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Quest Diagnostics Incorporated
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Type Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sonic Healthcare Limited
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Type Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. H.U. Group Holdings, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Type Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Kindstar Globalgene Technology, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Type Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Stanford Health Care
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Type Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Mayo Foundation for Medical Education and Research
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Type Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. ARUP Laboratories
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Type Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Athena Esoterix
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Type Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. ACM Global Laboratories
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Type Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Healius Limited.
      • 8.4.12.1. Company Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Type Benchmarking
      • 8.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Mexico esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 China esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 51 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Brazil esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Arabia esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Esoteric testing market: Market outlook
  • Fig. 10 Esoteric testing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Esoteric testing market driver impact
  • Fig. 16 Esoteric testing market restraint impact
  • Fig. 17 Esoteric testing market strategic initiatives analysis
  • Fig. 18 Esoteric testing market: Type movement analysis
  • Fig. 19 Esoteric testing market: Type outlook and key takeaways
  • Fig. 20 Oncology testing market estimates and forecast, 2018 - 2030
  • Fig. 21 Infectious disease testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Endocrinology testing market estimates and forecast, 2018 - 2030
  • Fig. 24 Toxicology testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Neurology testing market estimates and forecast, 2018 - 2030
  • Fig. 26 Other market estimates and forecast, 2018 - 2030
  • Fig. 27 Esoteric testing market: Technology movement analysis
  • Fig. 28 Esoteric testing market: Technology outlook and key takeaways
  • Fig. 29 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 30 Enzyme-linked immunosorbent assay market estimates and forecasts,2018 - 2030
  • Fig. 31 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 32 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
  • Fig. 33 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 34 Other market estimates and forecasts, 2018 - 2030
  • Fig. 35 Esoteric testing market: End use movement analysis
  • Fig. 36 Esoteric testing market: End use outlook and key takeaways
  • Fig. 37 Hospital-based laboratories esoteric testing market estimates and forecast, 2018 - 2030
  • Fig. 38 Independent and reference laboratories esoteric testing estimates and forecast, 2018 - 2030
  • Fig. 39 Global esoteric testing market: Regional movement analysis
  • Fig. 40 Global esoteric testing market: Regional outlook and key takeaways
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 44 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France market estimates and forecasts, 2018 - 2030
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 India market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 64 Middle East & Africa (MEA) market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030